Organization | Ospedale San Raffaele

Ospedale San Raffaele Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2015

NCT02542852

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Alberto Briganti | Emanuele Bosi | Giorgio Gandalgia | Michele Reni | Prof. Massimo Filippi | Scarlata, Simone, M.D. | Vito Cucchiara

Active Ingredients

Drugs in Phase 2 Trials (5)

atazanavir (reyataz) (1 trial)

chlorambucil (Leukeran) (1 trial)

dolutegravir (tivicay) (1 trial)

interferon beta-1a (Avonex) (1 trial)

ritonavir (Norvir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Viremia (Phase 2)

Virus Diseases (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 3
# of Trial APIs: 5